For psychedelic therapies to mature over the next few years into...

For psychedelic therapies to mature over the next few years into a set of new treatment options that are useful, safe, and accessible, the psychedelic research field has its work cut out. Future patients deserve nothing less.

Paul Liknaitzkyis head ofClinical Psychedelic Researchat Monash University, and chief Principal Investigator on a program of psychedelic trials at Monash University. He is a joint research fellow within the Department of Psychiatry (School of Clinical Sciences) and the Turner Institute for Brain and Mental Health (School of Psychological Sciences) at Monash University.

He is a member of the Medical Advisory Board of Incannex Healthcare Ltd with no executive role or equity in the company. He has received research funding from Incannex Healthcare Ltd, Dr Nigel Strauss, and the Multidisciplinary Association for Psychedelic Studies.

https://360info.org/preparing-for-psychedelic-therapies-in-australia/

Good luck all holders